Form 4: Outset Medical Executive Receives RSU Grant

Outset Medical, Inc. reports that EVP, Commercial Derick A. Elliott was granted 96,000 restricted stock units on April 6, 2026.

Summary

• Derick A. Elliott, EVP, Commercial at Outset Medical, Inc., received a grant of 96,000 restricted stock units (RSUs) on April 6, 2026.
• These RSUs represent a contingent right to receive one share of common stock each.
• Vesting is scheduled to occur in tranches: 33.33% on April 6, 2027, and the remaining 66.66% in equal quarterly installments over the following two years, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event rather than a significant financial or strategic development for the company.

Positives

• Grant of RSUs indicates a long-term incentive for the executive, aligning their interests with shareholders.
• The vesting schedule over multiple years encourages retention and sustained performance.

Risks

• The value of the RSUs is subject to the future performance of Outset Medical's stock price.
• Continued service is a condition for vesting, meaning the executive could forfeit unvested RSUs if they leave the company before the vesting dates.

Future Outlook

The future outlook for the RSUs is tied to the company's stock performance and the executive's continued employment, with specific vesting dates outlined for April 6, 2027, and quarterly thereafter over the subsequent two years.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock units to key executives is a common practice in the medical technology sector to incentivize long-term growth and align executive compensation with shareholder value.

Stakeholder Impact

• Shareholders: The RSU grant is a form of compensation, potentially diluting ownership slightly upon vesting, but also aims to align executive interests with long-term shareholder value.
• Employees: May signal a focus on executive retention and long-term incentives within the company.
• Management: The executive receives a performance-based incentive tied to company stock.

Next Steps

• Vesting of RSUs on April 6, 2027 (33.33%).
• Quarterly vesting of remaining RSUs over the following two years, subject to continuous service.

Key Dates

Keywords

Outset Medical, Form 4, Restricted Stock Units, RSU Grant, Executive Compensation, Securities Exchange Act, Beneficial Ownership, Derick Elliott